Sionna Therapeutics (NasdaqGM:SION) FY Conference November 11, 2025 08:30 AM ET Speaker3A different part of the protein, specifically NBD1, and I'm sure we'll get more into NBD1 and what its role in the biology is and how this is unique and different. Our goal really is to disrupt, in a positive way, the CF landscape. We think we have an opportunity to transform the treatment of patients and provide new options, potentially more efficacious options, with a goal of getting as many patients to normal CFTR fun ...